News | June 03, 2022
GSK to acquire clinical-stage biopharmaceutical company Affinivax for US$ 3.3 billion
GSK to pay $2.1 billion upfront and up to $1.2 billion in potential development milestones
GSK to pay $2.1 billion upfront and up to $1.2 billion in potential development milestones
Low-dose atropine has emerged as an effective approach to slow the progression of myopia in children
The partnership aims to enhance HotSpot's drug discovery and development efforts by incorporating GOSTAR's high-quality, annotated datasets into HotSpot's machine learning (ML) and artificial intelligence (AI) models
Pemetrexed for injection is indicated for the treatment of Antineoplastics (medications used to treat cancer)
This Keytruda combination is the first immunotherapy option approved in the EU for high-risk early-stage TNBC
The Toradol tablets, 10 mg brand and generic had U.S. sales of approximately US $ 16.8 million MAT for the most recent twelve months ending in March 2022 according to IQVIA
This lawsuit has been filed in the Pennsylvania Federal Court. NATCO and its marketing partner Mylan
The tablets have an estimated market size of US $ 548 million for twelve months ending December 2021 according to IQVIA
The hybrid congress will take place from 1-4 June in Copenhagen, as well as virtually
Dr Rupali Paranjape, an experienced regulatory and compliance consultant and author of Blue Ocean of Compliance shares insights on her book in an interview with Thomas C Thottathil, Editor, www.indianpharmapost.com
Subscribe To Our Newsletter & Stay Updated
